References
- Watanabe A, Yoshimura T, Mikami B, et al. Reaction mechanism of alanine racemase from Bacillus stearothermophilus. X-Ray crystallographic studies of the enzyme bound within-(5′-phosphopyridoxyl)alanine. J Biol Chem 2002;277:19166–72
- Abe H, Yoshikawa N, Sarower MG, Okada S. Physiological function and metabolism of free d-alanine in aquatic animals. Biol Pharm Bull 2005;28:1571–7
- Hoffmann K, Schneider-Scherzer E, Kleinkauf H, Zocher R. Purification and characterization of eucaryotic alanine racemase acting as key enzyme in cyclosporin biosynthesis. J Biol Chem 1994;269:12710–14
- Cheng YQ, Walton JD. A eukaryotic alanine racemase gene involved in cyclic peptide biosynthesis. J Biol Chem 2000;275:4906–11
- Uo T, Yoshimura T, Tanaka N, et al. Functional characterization of alanine racemase from Schizosaccharomyces pombe: a eucaryotic counterpart to bacterial alanine racemase. J Bacteriol 2001;83:2226–33
- Ono K, Yanagida K, Oikawa T, et al. Alanine racemase of alfalfa seedlings (Medicago sativa L.): first evidence for the presence of an amino acid racemase in plants. Phytochemistry 2006;67:856–60
- Moore BC, Leigh JA. Markerless mutagenesis in Methanococcus maripaludis demonstrates roles for alanine dehydrogenase, alanine racemase, and alanine permease. J Bacteriol 2005;187:972–9
- Benedetti SD, Buhl H, Gaballah A, et al. Characterization of serine hydroxymethyltransferase GlyA as a potential source of d-alanine in Chlamydia pneumonia. Front Cell Infect Microbiol 2014;4:19
- Kang L, Shaw AC, Xu D, et al. Upregulation of MetC Is essential for d-alanine-independent growth of an alr/dadX-deficient Escherichia coli strain. J Bacteriol 2011;193:1098–106
- Wild J, Hennig J, Lobocka M, et al. Identification of the dadX gene coding for the predominant isozyme of alanine racemase in Escherichia coli K12. Mol Gen Genet 1985;198:315–22
- Walsh CT. Enzymes in the d-alanine branch of bacterial cell wall peptidoglycan assembly. J Biol Chem 1989;64:2393–6
- Lobocka M, Hennig J, Wild J, Klopotowski T. Organization and expression of the Escherichia coli K-12 dad operon encoding the smaller subunit of d-amino acid dehydrogenase and the catabolic alanine racemase. J Bacteriol 1994;176:1500–10
- Strych U, Huang HC, Krause KL, Benedik MJ. Characterization of the alanine racemases from Pseudomonas aeruginosa PAO1. Curr Microbiol 2000;41:290–4
- McFall E, Newman EB. Alanine racemase enzyme inhibitors as antibacterial agents: a review. In: Neidhardt FC, ed. Escherichia coli and Salmonella: cellular and molecular biology. Washington DC: ASM Press; 1996:358–79
- Strych U, Benedik MJ. Mutant analysis shows that alanine racemases from Pseudomonas aeruginosa and Escherichia coli are dimeric. J Bacteriol 2002;184:4321–5
- LeMagueres P, Im H, Dvorak A, et al. Crystal structure at 1.45 Å resolution of alanine racemase from a pathogenic bacterium, Pseudomonas aeruginosa, contains both internal and external aldimine forms. Biochemistry 2003;42:14752–61
- LeMagueres P, Im H, Ebalunode J, et al. The 1.9 Å crystal structure of alanine racemase from Mycobacterium tuberculosis contains a conserved entryway into the active site. Biochemistry 2005;44:1471–81
- Priyadarshi A, Lee EH, Sung MW, et al. Structural insights into the alanine racemase from Enterococcus faecalis. Biochim Biophys Acta 2009;1794:1030–40
- Im H, Sharpe ML, Strych U, et al. The crystal structure of alanine racemase from Streptococcus pneumoniae, a target for structure-based drug design. BMC Microbiol 2011;11:116
- Shaw JP, Petsko GA, Ringe D. Determination of the structure of alanine racemase from Bacillus stearothermophilus at 1.9 A° resolution. Biochemistry 1997;36:1329–42
- (a) Mustata GI, Soares TA, Briggs JM. Molecular dynamics studies of alanine racemase: a structural model for drug design. Biopolymers 2003;70:186–200. (b) Mustata GI, Briggs JM. A structure-based design approach for the identification of novel inhibitors: application to an alanine racemase. J Comput Aided Mol Des 2002;16:935–53.
- Stamper GF, Morollo AA, Ringe D. Reaction of alanine racemase with 1-aminoethylphosphonic acid forms a stable external aldimine. Biochemistry 1998;37:10438–45
- Sun S, Toney MD. Evidence for a two-base mechanism involving tyrosine-265 from arginine-219 mutants of alanine racemase. Biochemistry 1999;38:4058–65
- Watanabe A, Yoshimura T, Mikami B, Esaki N. Tyrosine 265 of alanine racemase serves as a base abstracting a hydrogen from l-alanine: the counterpart residue to Lys39 specific to d-alanine. J Biochem 1999;126:781–6
- John RA. Pyridoxal phosphate-dependent enzymes. Biochim Biophys Acta 1995;1248:81–96
- Ondrechen MJ, Briggs JM, McCammon JA. A model for enzyme–substrate interaction in alanine racemase. J Am Chem Soc 2001;123:2830–4
- Watanabe A, Yoshimura T, Mikami B, Esaki N. Role of tyrosine 265 of alanine racemase from Bacillus stearothermophilus. J Biochem 1999;125:987–90
- Rubinstein A, Major DT. Understanding catalytic specificity in alanine racemase from quantum mechanical and molecular mechanical simulations of the arginine 219 mutant. Biochemistry 2010;49:3957–64
- Rubinstein A, Major DT. Catalyzing racemizations in the absence of a cofactor: the reaction mechanism in proline racemase. J Am Chem Soc 2009;131:8513–21
- Toney MD. Reaction specificity in pyridoxal phosphate enzymes. Arch Biochem Biophys 2005;433:279–87
- Davis E, Hutchinson ES, Reading HO, et al. The structure of alanine racemase from Acinetobacter baumannii. Acta Cryst 2014;F70:1199–205
- Strych U, Davlieva M, Longtin JP, et al. Purification and preliminary crystallization of alanine racemase from Streptococcus pneumonia. BMC Microbiol 2007;7:40
- Yoshimura T, Goto M. d-Amino acids in the brain: structure and function of pyridoxal phosphate-dependent amino acid racemases. FEBS J 2008;275:3527–37
- Morollo AA, Petsko GA, Ringe D. Structure of a Michaelis complex analogue: propionate binds in the substrate carboxylate site of alanine racemase. Biochemistry 1999;38:3293–301
- Fenn TD, Stamper GF, Morollo AA, Ringe D. A side reaction of alanine racemase: transamination of cycloserine. Biochemistry 2003;42:5775–83
- Olson GT, Mengmeng F, Lau S, et al. An aromatization mechanism of inactivation of d-aminobutyric acid aminotransferase for the antibiotic l-cycloserine. J Am Chem Soc 1998;120:2256–67
- Almo SL, Smith DL, Danishefsky AT, Ringe D. Structure of E. coli aspartate transaminase. Prot Eng 1994;7:405–12
- Lin YL, Gao J, Rubinstein A, Major DT. Molecular dynamics simulations of the intramolecular proton transfer and carbanion stabilization in the pyridoxal 5′-phosphate dependent enzymes l-dopa decarboxylase and alanine racemase. Biochim Biophys Acta 2011;814:1438–46
- Yoshimura T, Esaki N, Soda K. Structure and function of alanine racemase. Bull Inst Chem Res Kyoto Univ 1992;70:378–84
- Conti P, Tamborini L, Pinto A, et al. Drug discovery targeting amino acid racemases. Chem Rev 2011;111:6919–46
- Lynch JL, Neuhaus FC. On the mechanism of action of the antibiotic o-carbamyl-d-serine in Streptococcus faecalis. J Bacteriol 1966;91:449–60
- Skinner CG, Mccord TJ, Ravel JM, Shive W. O-Carbamyl-l-serine, an inhibitory analog of l-glutamine. J Am Chem Soc 1956;78:2412–14
- Lambert MP, Neuhaus FC. Mechanism of d-cycloserine action: alanine racemase from Escherichia coli W. J Bacteriol 1972;110:978–87
- Roze U, Strominger JL. Alanine racemase from Staphylococcus aureus: conformation of its substrates and its inhibitor, d-cycloserine. Mol Pharmacol 1966;2:92–4
- Manning MJ, Merrifield NE, Jones WM, Gotschlich EC. Inhibition of bacterial growth by 3-chloro-d-alanine. Proc Natl Acad Sci 1974;71:417–21
- Kim MG, Strych U, Krause K, et al. N(2)-substituted d,l-cycloserine derivatives: synthesis and evaluation as alanine racemase inhibitors. J Antibiot (Tokyo) 2003;56:160–8
- Atherton FR, Hall MJ, Hassall CH, et al. Phosphonopeptides as antibacterial agents: mechanism of action of alaphosphin. Antimicrob Agents Chemother 1979;15:696–705
- Wargel RJ, Shadur CA, Neuhaus FC. Mechanism of d-cycloserine action: transport mutants for d-alanine, d-cycloserine, and glycine. J Bacteriol 1971;105:1028–35
- Allen JG, Atherton FR, Hall MJ, et al. Phosphonopeptides as antibacterial agents: alaphosphin and related phosphonodipeptides. Antimicrob Agents Chemother 1979;15:684–95
- Atherton FR, Hall MJ, Hassall CH, et al. Phosphonopeptide antibacterial agents related to alafosfalin: design, synthesis, and structure–activity relationships. Antimicrob Agents Chemother 1980;18:897–905
- Atherton FR, Hall MJ, Hassall CH, et al. Antibacterial activity and mechanism of action of phosphonopeptides based on aminomethylphosphonic acid. Antimicrob Agents Chemother 1982;22:571–8
- Badet B, Walsh C. Purification of an alanine racemase from Streptococcus faecalis and analysis of its inactivation by (1-aminoethyl)phosphonic acid enantiomers. Biochemistry 1985;24:1333–41
- Badet B, Roise D, Walsh CT. Inactivation of the dadB Salmonella typhimurium alanine racemase by d and l isomers of beta-substituted alanines: kinetics, stoichiometry, active site peptide sequencing, and reaction mechanism. Biochemistry 1984;23:5188–94
- Flynn GA, Beight DW, Bohme EHW, Metcalf BW. The synthesis of fluorinated aminophosphonic acid inhibitors of alanine racemase. Tetrahedron Lett 1985;26:285–8
- Quang YV, Carniato D, Quang LV, et al. (1-Amino-2-propeny1) phosphonic acid, an inhibitor of alanine racemase and d-alanine–alanine ligase. J Med Chem 1986;29:579–81
- Quang YV, Carniato D, Quang LV, et al. (β-Chloro-α-aminoethyl)phosphonic acids as inhibitors of alanine racemase and d-alanine: d-alanine ligase. J Med Chem 1986;29:148–51
- Erion MD, Walsh CT. 1-Alanine racemase aminocyclopropanephosphonate: time-dependent inactivation of 1-aminocyclopropanecarboxylate deaminase and Bacillus stearothermophilus alanine racemase by slow dissociation behavior. Biochemistry 1987;26:3417–25
- Thornberry NA, Bull HG, Taub D, et al. 3-Halovinylglycines efficient irreversible inhibitors of Escherichia coli. J Am Chem Soc 1987;109:1543–4
- Baldwin JE, Haber SB, Hoskins C, Kruse LI. Synthesis of beta, gamma-unsaturated amino acids. J Org Chem 1977;42:1239–41
- Mobashery S, Johnston M. Reactions of Escherichia coli TEM β-lactamase with cephalothin and with C10-dipeptidyl cephalosporin esters. J Biol Chem 1986;261:7879–87
- Mobashery S, Lerner SA, Johnston M. Conscripting β-lactamase for use in drug deliver. Synthesis and biological activity of a cephalosporin C10-ester of an antibiotic dipeptide. J Am Chem Soc 1986;108:1685–6
- Mobashery S, Johnston M. Inactivation of alanine racemase by β-chloro-l-alanine released enzymatically from amino acid and peptidyl C10-esters of deacetylcephalothin. Biochemistry 1987;26:5878–84
- Patchett AA, Taub D, Weissberger B, et al. Antibacterial activities of fluorovinyl-and chlorovinylglycine and several derived dipeptides. Antimicrob Agents Chemother 1988;32:319–23
- Duncan K, Faraci WS, Matteson DS, Walsh CT. (1-Aminoethyl) boronic acid: a novel inhibitor for Bacillus stearothermophilus alanine racemase and Salmonella typhimurium d-alanine: d-alanine Ligase (ADP-Forming). Biochemistry 1989;28:3541–9
- Faraci WS, Walsh CT. Mechanism of inactivation of alanine racemase by β,β,β-trifluoroalanine. Biochemistry 1989;28:431–7
- Badet B, Inagaki K, Soda K, Walsh CT. Time-dependent inhibition of Bacillus stearothermophilus alanine racemase by (1-aminoethyl)phosphonate isomers by isomerization to noncovalent slowly dissociating enzyme-(1-aminoethyl)phosphonate complexes. Biochemistry 1986;25:3275–82
- Anthony KG, Strych U, Yeung KR, et al. New classes of alanine racemase inhibitors identified by high-throughput screening show antimicrobial activity against Mycobacterium tuberculosis. PLoS One 2011;6:e20374
- Ciustea M, Mootien S, Rosato AE, et al. Thiadiazolidinones: a new class of alanine racemase inhibitors with antimicrobial activity against methicillin-resistant Staphylococcus aureus. Biochem Pharmacol 2012;83:368–77
- Lee Y, Mootien S, Shoen C, et al. Inhibition of mycobacterial alanine racemase activity and growth by thiadiazolidinones. Biochem Pharmacol 2013;86:222–30